Risk communication in consultations about hormone therapy in the menopause:: concordance in risk assessment and framing due to the context

被引:8
|
作者
Hoffmann, M.
Hammar, M.
Kjellgren, K. I.
Lindh-Astrand, L.
Ahlner, J.
机构
[1] Linkoping Univ, Div Clin Pharmacol, Dept Med & Care, Fac Hlth Sci, Linkoping, Sweden
[2] Linkoping Univ, Dept Obstet & Gynecol, Dept Mol & Clin Med, Fac Hlth Sci, Linkoping, Sweden
[3] Univ Gothenburg, Sahlgrenska Acad, Inst Nursing, Fac Hlth & Caring Sci, Gothenburg, Sweden
[4] Nalt Board Forens Med, Dept Forens Chem, Linkoping, Sweden
关键词
risk; risk assessment; communication; physician-patient relations; professional-patient relations;
D O I
10.1080/13697130600870220
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background It is important for the physician and the patient to have a mutual understanding of the possible consequences of different treatment alternatives in order to achieve a partnership in decision-making. Objective The aim of this study was to explore to which degree first-time consultations for discussion of climacteric discomfort achieved shared understanding of the risks and benefits associated with hormone therapy in the menopausal transition. Methods Analysis of structure and content of transcribed consultations (n=20), and follow-up interviews of the women (n=19 pairs of consultations and interviews), from first-time visits for discussion of climacteric discomfort and/or HT with five physicians at three different outpatient clinics of gynecology in Sweden. Results Four distinctively different interpretations of risk, depending on whether or not benefits were discussed in the same context, emerged from the analysis. On average, five advantages (range 0-11) and two (0-3) disadvantages were mentioned during the consultations. In the interviews, the women expressed on average four advantages (0-7) and one disadvantage (0-3). There were major variations between advantages and disadvantages expressed in the consultation and the following interview. Conclusion Even though the consultations scored high in patient involvement, the information in most consultations was not structured in a way that made it possible to achieve a shared or an informed decision-taking.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 50 条
  • [1] Women's views of optimal risk communication and decision making in general practice consultations about the menopause and hormone replacement therapy
    Walter, FM
    Emery, JD
    Rogers, M
    Britten, N
    PATIENT EDUCATION AND COUNSELING, 2004, 53 (02) : 121 - 128
  • [2] Dementia: Increased risk due to hormone therapy during menopause?
    Simon, Annika
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (22) : 1401 - 1402
  • [3] Menopause, hormone therapy and breast cancer risk
    La Vecchia, C
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2003, 12 (05) : 437 - 438
  • [4] Menopause hormone therapy and the risk of thromboembolic disease
    Kotarski, Jan
    Barczynski, Bartlomiej
    Kwasniewski, Wojciech
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2011, 10 (04): : 275 - 278
  • [5] Menopause, vascular risk and hormone replacement therapy
    Garnier, LF
    Bourges, O
    PRESSE MEDICALE, 2000, 29 (18): : 1013 - 1018
  • [6] HORMONE-THERAPY AND RISK OF CANCER IN MENOPAUSE
    KUHL, H
    TAUBERT, HD
    GYNAKOLOGE, 1986, 19 (04): : 259 - 265
  • [7] Hormone replacement therapy after menopause - new knowledge about long term risk
    Gjelsvik, Bjorn
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2018, 138 (01) : 8 - 8
  • [8] Vascular risk in menopause: impact of hormone replacement therapy
    Chiche, GJ
    PRESSE MEDICALE, 2001, 30 (05): : 229 - 229
  • [9] Menopause and postmenopausal hormone therapy and risk of hearing loss
    Curhan, Sharon G.
    Eliassen, A. Heather
    Eavey, Roland D.
    Wang, Molin
    Lin, Brian M.
    Curhan, Gary C.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (09): : 1049 - 1056
  • [10] Hormone therapy in the menopause and breast cancer risk - A review
    Ewertz, M
    MATURITAS, 1996, 23 (02) : 241 - 246